Fairvalue-Calculator Fairvalue-Calculator
EN DE

Optimi Health Corp (OPTH) Fair Value & Analysis

Healthcare · US · Market cap $28.3M

Price$4.17
Fair Value$2.46
Upside-41.0%
Quality91/100
Evidence: Low Range $1.85 – $3.08

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Optimi Health Corp (OPTH) currently trades at $4.17, while our model-based Fair Value estimate is $2.46 — implying the stock looks roughly 41.0% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1949% Jiangsu Hengrui Pharmaceuticals Co (600276) -46% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -74% Hansoh Pharmaceutical Group (3692) -47% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Optimi Health Corp (OPTH) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $2.46 versus a price of $4.17 — about −41% (overvalued). Model-based estimate, not financial advice.
What is the fair value of OPTH?
Our 21-model fair value for Optimi Health Corp is $2.46 (as of Jun 24, 2026), built from audited fundamentals. The current price is $4.17.
What is the quality score of OPTH?
Optimi Health Corp has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.